Pharma Mar, S.A. (OTCMKTS:PHMMF) Sees Significant Growth in Short Interest

Pharma Mar, S.A. (OTCMKTS:PHMMF) was the target of a significant increase in short interest in October. As of October 31st, there was short interest totalling 26,600 shares, an increase of 116.3% from the October 15th total of 12,300 shares. Based on an average daily volume of 100 shares, the short-interest ratio is currently 266.0 days.

Pharma Mar Price Performance

PHMMF stock remained flat at $75.00 during trading on Wednesday. 50 shares of the company were exchanged, compared to its average volume of 24. Pharma Mar has a one year low of $26.85 and a one year high of $75.00. The company has a quick ratio of 2.01, a current ratio of 2.55 and a debt-to-equity ratio of 0.14. The business has a fifty day simple moving average of $59.44 and a 200-day simple moving average of $42.38.

Wall Street Analysts Forecast Growth

Separately, Chardan Capital upgraded Pharma Mar to a “strong-buy” rating in a research note on Thursday, August 1st.

Pharma Mar Company Profile

Pharma Mar, SA, a biopharmaceutical company, engages in the research, development, production, and commercialization of bio-active principles for the use in oncology in Spain, Italy, Germany, Ireland, France, rest of the European Union, the United States, and internationally. The company operates through Oncology and RNA Interference segments.